Antigenic variation of SIV: Mutations in V4 alter the neutralization profile

Virology

Volumn 221, Issue 1, 1996, Pages 14-21

  Kinsey, Nicole E ^a   Anderson, Mark G ^b   Unangst, Tami J ^a   Joag, Sanjay V ^c   Narayan, Opendra ^c   Zink, M Christine ^a   Clements, Janice E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Augusta Medical Center   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; MONOCLONAL ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGENIC VARIATION; ARTICLE; BLOOD SAMPLING; GENE MAPPING; GENE MUTATION; MACACA; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RADIOIMMUNOPRECIPITATION; RETROVIRUS INFECTION; SEQUENCE ANALYSIS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT;

EID: 0030198878     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0348     Document Type: Article

References (52)

1. Albert, J., Abrahamsson, B., Nagy, K., Aurelius, E., Gaines, H., Nystrom, G., and Fenyo, E. M. (1990). Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 4, 107-112.
2. Back, N. K., Smit, L., De Jong, J. J., Keulen, W., Schutten, M., Goudsmit, J., and Tersmette, M. (1994). An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. Virology 199, 431-438.
3. Balfe, P., Simmonds, P., Ludlam, C. A., Bishop, J. O., and Brown, A. J. L. (1990). Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: Rate of sequence change and low frequency of inactivating mutations. J. Virol. 64, 6221-6233.
4. Benichou, S., Legrand, R., Nakagawa, N., Faure, T., Traincard, F., Vogt, G., Dormont, D., Tiollais, P., Kieny, M.-P., and Madaule, P. (1992). Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 8, 1165-1170.
5. Broliden, P. A., von Gegerfelt, A., Clapham, P., Rosen, J., Fenyo, E. M., Wahren, B., and Broliden, K. (1992). Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Proc. Natl. Acad. Sci. USA 89, 461-465.
6. Burns, D. P. W., and Desrosiers, R. C. (1991). Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. J. Virol. 65, 1843-1854.
7. Chanh, T. C., Dressman, G. R., Kanda, P., Linette, G. P., Sparrow, J. T., Ho, D. D., and Kennedy, R. C. (1986). Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J. 5, 3065-3071.
8. Choi, W. S., Collignon, C., Thiriart, C., Burns, D. P. W., Stott, E. J., Kent, K. A., and Desrosiers, R. C. (1994). Effects of natural sequence variation on recognition by monoclonal antibodies that neutralize simian immunodeficiency virus infectivity. J. Virol. 68, 5395-5402.
9. Clements, J. E., Gdovin, S. L., Montelaro, R. C., and Narayan, O. (1988). Antigenic variation in lentiviral diseases. Annu. Rev. Immunol. 6, 139-159.
10. Clements, J. E., Petersen, F. S., Narayan, O., and Haseltine, W. S. (1980). Genomic changes associated with antigenic variation of visna virus during persistent infection. Proc. Natl. Acad. Sci. USA 77, 4454-4458.
11. Clements, J. E., Wall, R. J., Narayan, O., Hauer, D., Schoborg, R., Sheffer, D., Powell, A., Carruth, L. M., Zink, M. C., and Rexroad, C. E. (1994). Development of transgenic sheep that express the visna virus envelope gene. Virology 200, 370-380.
12. Domingo, E. (1989). RNA virus evolution and the control of viral disease. Prog. Drug. Res. 33, 93-139.
13. Fenouillet, E., and Gluckman, J. C. (1991). Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein. J. Gen. Virol. 72, 1919-1926.
14. Fung, M. S., Sun, C. R., Gordon, W. L., Liou, R. S., Chang, T. W., Sun, W. N., Daar, E. S., and Ho, D. D. (1992). Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120. J. Virol. 66, 848-856.
15. Gnann, J. W., Nelson, J. A., and Oldstone, M. B. (1987). Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. J. Virol. 61, 2639-2641.
16. Goodenow, M., Huet, T., Saurin, W., Kwok, S., Sninsky, J., and Wain-Hobson, S. (1989). HIV-1 isolates are rapidly evolving quasispecies: Evidence for viral mixtures and preferred nucleotide substitutions. J. Acquired Immune Defic. Syndr. 2, 344-352.
17. Goudsmit, J., Debouck, C., Meloen, R. H., Smit, L., Bakker, M., Asher, D. M., Wolf, A. V., Gibbs, C. J., and Gajdusek, D. C. (1988). HIV-1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc. Natl. Acad. Sci. USA 85, 4478-4482.
18. Griffin, D. E., Narayan, O., and Adams, R. J. (1978). Early immune responses in visna, a slow viral disease of sheep. J. Infect. Dis. 138, 340-350.
19. Gudnadottir, M. (1974). Visna-maedi in sheep. Prog. Med. Virol. 18, 336-349.
20. Hahn, B. H., Shaw, G. M., Taylor, M. E., Redfield, R. R., Markham, P. D., Salahuddin, S. Z., Wong-Staal, F., Gallo, R. C., Parks, E. S., and Parks, W. P. (1986). Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science 232, 1548-1553.
21. Ho, D. D., Kaplan, J. C., Rackauskas, I. E., and Gurney, M. E. (1988). Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization. Science 239, 1021-1023.
22. Ho, D. D., Sarngadharan, M. G., Hirsch, M. S., Schooley, R. T., Rota, T. R., Kennedy, R. C., Chanh, T. C., and Sato, V. L. (1987). Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. J. Virol. 61, 2024-2028.
23. Holland, J. J., De La Torre, J. E., and Steinhauer, D. A. (1992). RNA virus populations as quasispecies. Curr. Top. Microbiol. 176, 1-20.
24. Huso, D. L., Narayan, O., and Hart, G. W. (1988). Sialic acids on the surface of caprine arthritis encephalitis virus define the biological properties of the virus. J. Virol. 62, 1974-1988.
25. Javaherian, K., Langlois, A. J., LaRosa, G. J., Profy, A. T., Bolognesi, D. P., Herlihy, W. C., Putney, S. D., and Matthews, T. J. (1990). Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. Science 250, 1590-1593.
26. Javaherian, K., Langlois, A. J., Schmidt, S., Kaufmann, M., Gates, N., Langedijk, J. P. M., Meloen, R. H., Desrosiers, R. C., Burns, D. P. W., Bolognesi, D. P., LaRosa, G. J., and Putney, S. D. (1992). The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89, 1418-1422.
27. Jbag, S. V., Anderson, M. G., Clements, J. E., McEntee, M. F., Sharma, D. P., Adams, R. J., and Narayan, O. (1993). Antigenic variation of molecularly cloned SIVmac239 during persistent infection in a rhesus macaque. Virology 195, 406-412.
28. Katz, R. A., and Skalka, A. M. (1990). Generation of diversity in retroviruses. Annu. Rev. Genet. 24, 409-445.
29. Kent, K. A., Rud, E., Corcoran, T., Powell, C., Thiriart, C., Collignon, C., and Stott, E. J. (1992). Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies. AIDS Res. Hum. Retroviruses 8, 1147-1151.
30. Kodama, T., Burns, D. P., Silva, D. P., Veronese, F. D., and Desrosiers, R. C. (1991). Strain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency virus. J. Virol. 65, 2010-2018.
31. Kono, Y. (1988). Antigenic variation of equine infectious anemia virus as detected by virus neutralization. Arch. Virol. 98, 91-97.
32. Kono, Y., Kobayaski, K., and Fukunaga, Y. (1973). Antigenic drift of equine infectious anemia virus in chronically infected horses. Arch. Virusforsch. 41, 1-10.
33. Li, Yan, Luo, Lizhong, Rasool, Nassar, and Kang, C. Y. (1993). Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. J. Virol. 67, 584-588.
34. Matsushita, S., Robert-Guroff, M., Rusche, J., Koito, A., Hattori, T., Hoshino, H., Javaherian, K., Takatsuki, K., and Putney, S. (1988). Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J. Virol. 62, 2107-2114.
35. McEntee, M. F., Anderson, M. G., Daniel, M. D., Adams, R., Farzadegan, H., Desrosiers, R. C., and Narayan, O. (1992). Differences in neutralization of simian lentivirus (SIVmac) in lymphocyte and macrophage cultures. AIDS Res. Hum. Retroviruses 8, 1193-1198.
36. Montelaro, R. C., Parekh, B., Orrego, A., and Issel, C. J. (1984). Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus. J. Biol. Chem. 259, 10539-10544.
37. Montelaro, R. C., West, M., and Issel, C. J. (1984). Antigenic reactivity of the major glycoprotein of equine infectious anemia virus, a retrovirus. Virology 136, 368-374.
38. Narayan, O., and Clements, J. E. (1990). Lentiviruses. In "Fields Virology." 2nd ed., Chap. 55, pp. 1571-1589. (B. N. Relds and D. M. Knipe, Eds.) Raven Press, New York.
39. Narayan, O., Clements, J. E., Griffin, D. E., and Wolinsky, J. S. (1981). Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus. Infect. Immun. 32, 1045-1050.
40. Narayan, O., Griffin, D. E., and Chase, J. (1977a). Antigenic drift of visna virus in persistently infected sheep. Science 197, 376-378.
41. Narayan, O., Griffin, D. E., and Silverstein, A. M. (1977b). Slow virus infection: Replication and mechanisms of persistence of visna virus in sheep. J. Infect. Dis. 135, 800-806.
42. Payne, S. L., Rushlow, K., Dhruva, B. R., Issel, C. J., and Montelaro, R. C. (1989). Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli. Virology 172, 609-615.
43. Regier, D. A., and Desrosiers, R. C. (1990). The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 6, 1221-1231.
44. Robert-Guroff, M., Brown, M., and Gallo, R. C. (1985). HTLV-III-neutralizing antibodies in patients with AIDS and AIDS related complex. Nature 316, 72-74.
45. Robert-Guroff, M., Reitz, M. S., Robey, W. G., and Gallo, R. C. (1986). In vitro generation of an HTLV-III variant by neutralizing antibody. J. Immunol. 137, 3306-3309.
46. Saag, M. S., Hahn, B. H., Gibbons, J., Li, Y., Parks, E. S., Parks, W. P., and Shaw, G. M. (1988). Extensive variation of human immunodeficiency virus type-1 in vivo. Nature 334, 440-444.
47. Sanger, F., Nicklen, S., and Coulsen, A. R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
48. Simmonds, P., Balfe, P., Ludlam, C. A., Bishop, J. O., and Brown, A. J. L. (1990). Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J. Wol. 64, 5840-5850.
49. Skinner, M., Langlois, A., McDanal, C., McDougal, J. S., Bolognesi, D., and Matthews, T. (1988). Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. J. Wol. 62, 4195-4200.
50. Torres, J. V., Malley, A., Banapour, B., Anderson, D. E., Axthelm, M. K., Gardner, M. B., and Benjamini, E. (1993). An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation. AIDS Res. Hum. Retroviruses 9, 423-430.
51. Tremblay, M., and Wainberg, M. A. (1990). Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera. J. Infect. Dis. 162, 735-737.
52. Zhu, T., Mo, H., Wang, N., Nam, D. S., Cao, Y., Koup, R. A., and Ho, D. D. (1993). Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261, 1179-1181.